​

Adaptive Bio Ownership | Who Owns Adaptive Bio?

OverviewForecastRevenueFinancialsChartTranscripts

Adaptive Bio Ownership Summary

Adaptive Bio is owned by 102.45% institutional investors, 2.36% insiders. Viking global investors lp is the largest institutional shareholder, holding 19.72% of ADPT shares. ARK Genomic Revolution is the top mutual fund, with 5.13% of its assets in Adaptive Bio shares.

ADPT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAdaptive Bio102.45%2.36%-4.80%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Viking global investors lp29.99M19.72%$349.43M
Rubric capital management lp14.60M9.90%$87.53M
Blackrock funding, inc. /de13.67M8.99%$159.22M
Vanguard group10.71M7.26%$64.24M
Sumitomo mitsui trust6.83M4.63%$40.96M
Millennium management6.29M4.27%$37.72M
Nikko asset management americas4.30M2.83%$50.05M
Ark investment management4.02M2.64%$46.79M
Braidwell lp3.86M2.54%$45.01M
Aristotle atlantic partners2.88M1.89%$33.54M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue water life science advisors, lp2.15M19.78%$24.99M
Pier capital1.02M1.81%$11.85M
Braidwell lp3.86M1.54%$45.01M
Rubric capital management lp14.60M1.12%$87.53M
Aristotle atlantic partners2.88M1.02%$33.54M
Viking global investors lp29.99M1.01%$349.43M
Essex investment management625.84K0.67%$3.75M
Options solutions151.59K0.53%$1.77M
Nikko asset management americas4.30M0.50%$50.05M
Harvest investment services168.28K0.44%$1.96M

Top Buyers

HolderShares% AssetsChange
Voya investment management2.43M0.02%2.39M
Fred alger management2.36M0.12%2.36M
Blackrock funding, inc. /de13.67M0.00%1.44M
Point72 asset management1.37M0.03%1.37M
Peregrine capital management702.71K0.25%702.71K

Top Sellers

HolderShares% AssetsChange
Ark investment management4.02M0.34%-3.72M
Millennium management6.29M0.02%-3.11M
Nikko asset management americas4.30M0.50%-1.79M
Braidwell lp3.86M1.54%-940.69K
Perceptive advisors---930.97K

New Positions

HolderShares% AssetsChangeValue
Fred alger management2.36M0.12%2.36M$27.44M
Peregrine capital management702.71K0.25%702.71K$8.19M
Oberweis asset management inc/589.40K0.30%589.40K$6.87M
Qube research364.77K0.00%364.77K$4.25M
Zimmer partners, lp252.90K0.06%252.90K$2.95M

Sold Out

HolderChange
Northwestern mutual wealth management-24.00
Stephens consulting-45.00
Srs capital advisors-97.00
Bokf, na-116.00
Rise advisors-119.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252278.10%152,848,9696.73%1021.09%1130.89%6544.44%
Dec 31, 202420911.17%143,202,0650.07%971.03%11114.43%452.27%
Sep 30, 20241886.21%143,105,692-3.74%970.93%975.43%44-4.35%
Jun 30, 2024177-7.81%148,665,2304.35%1011.07%926.98%46-30.30%
Mar 31, 2024192-4.48%142,469,885-0.71%970.99%86-10.42%66-8.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Genomic Revolution7.62M5.13%-1.68M
Vanguard Total Stock Mkt Idx Inv4.49M2.96%1.06K
Vanguard US Total Market Shares ETF4.19M2.82%-
ARK Genomic Revolution ETF3.61M2.38%-21.68K
Nikko AM ARK Pstv Chg Innovt P JPY Acc3.56M2.34%-116.30K
iShares Russell 2000 ETF3.53M2.32%-67.20K
Columbia Large Cap Growth V3.25M2.19%3.25M
Columbia Large Cap Growth SMA Cmp3.25M2.19%3.25M
Columbia Large Cap Growth3.25M2.19%3.25M
Nikko Gbl All Biological Genome Eq MF2.06M1.40%-121.82K

Recent Insider Transactions

DateNameRoleActivityValue
May 16, 2025PISKEL KYLE Chief Financial OfficerSell$17.15K
May 16, 2025PISKEL KYLE Chief Financial OfficerSell$17.15K
May 01, 2025ROBINS HARLAN S Chief Scientific OfficerSell$502.83K
Mar 24, 2025ROBINS HARLAN S Chief Scientific OfficerSell$15.28K
Mar 13, 2025GRIFFIN MICHELLE RENEE-Sell$260.93K

Insider Transactions Trends

DateBuySell
2025 Q1-25
2024 Q4-1
2024 Q3-1
2024 Q2--
2024 Q1-14

ADPT Ownership FAQ

Who Owns Adaptive Bio?

Adaptive Bio shareholders are primarily institutional investors at 102.45%, followed by 2.36% insiders and -4.81% retail investors. The average institutional ownership in Adaptive Bio's industry, Biotech Stocks , is 64.05%, which Adaptive Bio exceeds.

Who owns the most shares of Adaptive Bio?

Adaptive Bio’s largest shareholders are Viking global investors lp (29.99M shares, 19.72%), Rubric capital management lp (14.6M shares, 9.90%), and Blackrock funding, inc. /de (13.67M shares, 8.99%). Together, they hold 38.61% of Adaptive Bio’s total shares outstanding.

Does Blackrock own Adaptive Bio?

BlackRock is not among the top 10 institutional shareholders of Adaptive Bio.

Who is Adaptive Bio’s biggest shareholder by percentage of total assets invested?

Blue water life science advisors, lp is Adaptive Bio’s biggest shareholder by percentage of total assets invested, with 19.78% of its assets in 2.15M Adaptive Bio shares, valued at 24.99M$.

Who is the top mutual fund holder of Adaptive Bio shares?

ARK Genomic Revolution is the top mutual fund holder of Adaptive Bio shares, with 5.13% of its total shares outstanding invested in 7.62M Adaptive Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools